Skip to Content

M MT1 (Metoprolol succinate extended-release 25 mg)

Pill imprint M MT1 has been identified as Metoprolol succinate extended-release 25 mg.

Metoprolol is used in the treatment of atrial fibrillation; high blood pressure; supraventricular tachycardia; benign essential tremor; migraine prevention (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Metoprolol succinate extended-release 25 mg M MT1
Metoprolol succinate extended-release
Imprint:
M MT1
Strength:
25 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Cardioselective beta blockers
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4595
Inactive Ingredients:
silicon dioxide
ethylcelluloses
hypromelloses
lactose monohydrate
microcrystalline cellulose
polyethylene glycol
sodium stearyl fumarate
titanium dioxide
triacetin

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide